Product & Service Providers in: MANUFACTURING: 503B Outsourcing Facilities, Compounding Services DISTRIBUTION: 340B Solutions, Management Systems COMPOUNDING: Sterile Compounding, IV Automation PATIENT CARE: Adherence, Compliance As Seen In: View
We are excited to announce the expansion of our IV Bag portfolio with new arrivals now available for preorder: ✔️ Fentanyl 10 mcg/mL, 100 mL
Back in July, we proudly announced that we were stepping into the oncology shortage market to serve as a reliable supplier for hospitals and healthcare
Improving the Supply of Critical Medications for Pediatric and Adult Cancer Patients Columbus, OH – August 1, 2024 – STAQ Pharma, a hospital-owned 503B outsourcing
Now Available: Ropivacaine HCl 0.2% in Sodium Chloride, preservative free with a 180 Day Beyond Use Date (BUD). As a reliable partner to source from,
Denver, CO – March 6, 2024 – STAQ Pharma, a leading 503B Outsourcing Facility, is pleased to announce its selection of the prestigious 2024 Heartbeat
Supply from STAQ! Preservative Free Ketamine now available! As a reliable partner to source from, we are continuously seeking innovative solutions to enhance our product
Drug shortages pose a critical global health challenge, compromising patient care and treatment outcomes. Influencing factors include manufacturing issues, regulatory hurdles, supply chain disruptions, and
Bringing safety, transparency, availability, and quality to compounded medications. Safety Providing the right dosage of medication available in pre-filled syringes produced in a sterile, cGMP-compliant
STAQ Pharma is working with the nonprofit scientific research organization IAVI to provide support services for the production of an innovative intranasal spray targeting COVID-19.
